Senior Managing Partner & Founder, Phoenix IP Ventures
Osagie has over 30 years of experience in the field of law, finance, business management, healthcare and the pharmaceutical industry. He is a co-founder of PIPV Capital, a Private Equity Firm that is focused on the Life Sciences vertical, which was founded in 2004 and has invested over $1 Billion in institutional money. Prior to co-founding PIPV Capital, Osagie conceptualized and established GlaxoSmithKline Ventures and was its founding Vice President.
Osagie has held senior commercial and R&D positions within pharmaceutical companies such as GSK, SmithKline, DuPont Merck and Endo, where he was the founding General Counsel and SVP for Corporate Development. Osagie has also been a Price Waterhouse Corporate Finance Partner as well as a practicing attorney with a leading US Law Firm, Schnader, Harrison, Segal & Lewis.
Osagie is a serial entrepreneur and investor. He serves as Chairman and Founder of Ilera Healthcare as well as a Director of iCeutica Inc. Osagie was the Founder and Chairman of Ception Therapeutics Inc. and Trigenesis Therapeutics Inc. In addition, he serves on the Board of a number of financial institutions such as Haverford Trust (over $7 Billion in AUM) and StoneRidge Investment (over $2 Billion in AUM).
In addition, Osagie is active in philanthropic artistic pursuits and serves on the Executive Committee of the Board of the Philadelphia Orchestra and the Philadelphia Museum of Art.
Osagie is a Trustee of the University of Pennsylvania, a member of the Executive Committee of the University and Chairman of the Budget and Finance Committee of the University. Osagie is also a member of the Board of Overseers of the University of Pennsylvania Law School, where he is an Adjunct Professor of Intellectual Property Law. Osagie holds post-graduate degrees from the University of Pennsylvania Law School and the London School of Economics and is a member of the New York Bar.